Understanding Genitourinary Syndrome of Menopause (GSM): Pathophysiology, Clinical Presentation, Diagnostics, and Evidence-Based Management Genitourinary Syndrome of Menopause (GSM) is a chronic, progressive medical condition that affects over 50% of postmenopausal women. Formally defined in 2014 by a consensus panel from the International Society for the Study of Women’s Sexual Health (ISSWSH) and the North American Menopause Society (NAMS),...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Navigating Genitourinary Syndrome of Menopause (GSM): Underlying Causes, Clinical Diagnosis, and Evidence-Based Treatments Genitourinary Syndrome of Menopause (GSM)—a comprehensive medical term encompassing conditions historically referred to as vulvovaginal atrophy (VVA) or atrophic vaginitis—is a chronic, progressive condition that affects up to 50% of postmenopausal women. Despite its high prevalence, GSM remains significantly underreported...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Understanding Genitourinary Syndrome of Menopause (GSM): Pathophysiology, Diagnostics, and Evidence-Based Management in Post-Cancer Care For many women undergoing cancer treatment or transitioning into post-cancer survivorship, physical changes in intimate health can be among the most challenging yet under-addressed aspects of recovery. Symptoms such as severe vaginal dryness, burning, loss of elasticity, and painful intercourse (dyspareunia)...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Understanding Genitourinary Syndrome of Menopause (GSM): Symptoms, Pathophysiology, Diagnostics, and Treatment Options What is Genitourinary Syndrome of Menopause? Genitourinary Syndrome of Menopause (GSM), previously termed vulvovaginal atrophy (VVA) or atrophic vaginitis, is a chronic, progressive medical condition caused by systemic or localized oestrogen deficiency. The term GSM was formally adopted in 2014 by the International Society for...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Understanding Genitourinary Syndrome of Menopause (GSM): A Comprehensive Guide to Causes, Diagnostics, and Regenerative Therapies Genitourinary Syndrome of Menopause (GSM)—historically referred to as vulvovaginal atrophy (VVA) or atrophic vaginitis—is a chronic, progressive, and highly prevalent condition affecting between 50% and 84% of postmenopausal women. Unlike vasomotor symptoms (such as hot flushes), which often peak during the early...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Understanding Genitourinary Syndrome of Menopause (GSM): Causes, Symptoms, Diagnostic Steps, and Advanced Treatments For millions of women, the menopausal transition introduces quiet, unexpected changes to intimate health. While vasomotor symptoms like hot flushes and night sweats are widely discussed, changes in vaginal and urinary comfort often remain unmentioned due to embarrassment or the misconception that discomfort is simply an inevitable...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Understanding Genitourinary Syndrome of Menopause (GSM): Symptoms, Causes, and Modern Treatment Options Genitourinary Syndrome of Menopause (GSM)—historically termed Vulvovaginal Atrophy (VVA) or atrophic vaginitis—is a chronic, progressive hypoestrogenic condition affecting between 50% and 70% of postmenopausal women, as well as many cancer survivors undergoing anti-oestrogen therapies. Despite its high prevalence and significant impact on...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Understanding Genitourinary Syndrome of Menopause (GSM): A Patient’s Guide to Symptoms, Causes, and Evidence-Based Treatments --- What is Genitourinary Syndrome of Menopause (GSM)? For decades, the physical changes affecting the intimate areas after menopause were described simply as "vulvovaginal atrophy" (VVA). However, in 2014, leading international bodies—including the International Society for the Study of Women's Sexual Health (ISSWSH) and...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Understanding Genitourinary Syndrome of Menopause (GSM): Causes, Symptoms, and Evidence-Based Treatments Menopause is a natural biological milestone, yet many of its associated physical changes remain shrouded in silence. While vasomotor symptoms like hot flushes and night sweats are widely recognised and often ease over time, another group of symptoms affecting the intimate and urinary areas tends to persist and worsen if left unaddressed....Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Understanding Genitourinary Syndrome of Menopause (GSM): Causes, Symptoms, and Evidence-Based Treatments When people talk about menopause, hot flushes and night sweats usually dominate the conversation. However, for millions of women and individuals navigating midlife, some of the most bothersome and persistent changes happen quietly in the pelvic region. If you have experienced persistent vaginal dryness, discomfort during intimacy, an urgent...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.